Related Experiment Videos
Hepatocellular carcinoma in young, mentally retarded HBsAg carriers without cirrhosis
Insights
Hepatocellular carcinoma, a type of liver cancer, was found in young male Hepatitis B surface antigen (HBsAg) carriers. This cancer occurred without cirrhosis and was rapidly fatal, with incidence 246 times higher than in the general male population.
Area of Science:
- Hepatology
- Oncology
- Virology
Background:
- Hepatocellular carcinoma (HCC) is a primary liver cancer.
- Hepatitis B virus (HBV) infection is a major risk factor for HCC.
- Surveillance of mortality in institutionalized populations can reveal disease patterns.
Observation:
- Autopsies of 138 deaths at a Californian institution identified three cases of hepatocellular carcinoma.
- The cases occurred in young (mean age 26 years) male carriers of Hepatitis B surface antigen (HBsAg).
- These HCC cases were not associated with cirrhosis and were of the nonfibrolamellar oncocytic type.
Findings:
- Hepatocellular carcinoma incidence in HBsAg carriers was estimated to be 246 times greater than in United States males.
- The identified HCC cases were rapidly fatal.
- The nonfibrolamellar oncocytic subtype of HCC was observed.
Implications:
- Early detection and management strategies for HCC in HBsAg carriers are crucial.
- This study highlights the aggressive nature of HCC in young HBsAg carriers.
- Further research into the pathogenesis of nonfibrolamellar HCC in HBV carriers is warranted.
Abstract:
In a Californian institution for the mentally retarded, surveillance by autopsy of all deaths (n = 138) identified three cases of hepatocellular carcinoma. Hepatocellular carcinoma cases occurred in young (mean age = 26 years) male carriers of HBsAg and were not associated with cirrhosis. They were of the nonfibrolamellar oncocytic type and were rapidly fatal. Hepatocellular carcinoma incidence in HBsAg carriers was estimated to be 246 times greater than United States males.